Added to YB: 2024-09-24
Pitch date: 2024-09-24
IKNA [bullish]
Ikena Oncology, Inc.
-15.88%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
Market Cap
$69.0M
Pitch Price
$20.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.58
P/E
-2.24
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
IKENA ONCOLOGY INC IKNA
A summary for this pitch has not been created yet.
Read full article (0 min)